昊帆生物
(301393)
| 流通市值：26.57亿 | | | 总市值：65.28亿 |
| 流通股本：4396.77万 | | | 总股本：1.08亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 379,224,583 | 171,932,875.31 | 602,261,319.28 | 434,698,213.66 |
| 营业总成本 | 308,734,317.86 | 140,790,057 | 485,012,926.06 | 336,820,135.14 |
| 其他经营收益 | | | | |
| 营业利润 | 81,653,082.14 | 37,687,037.98 | 144,255,124.7 | 114,599,335.72 |
| 利润总额 | 81,453,698.28 | 37,629,744.48 | 129,270,198.3 | 113,826,751.78 |
| 净利润 | 69,391,051.35 | 32,714,039.46 | 110,844,322.74 | 99,238,347.92 |
| 每股收益 | | | | |
| 其他综合收益 | 49,949.13 | 77,060.21 | 106,026.85 | 132,740.77 |
| 综合收益总额 | 69,441,000.48 | 32,791,099.67 | 110,950,349.59 | 99,371,088.69 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,716,798,732.98 | 1,759,725,306.72 | 1,689,998,951.28 | 1,835,895,685.8 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,162,780,054.15 | 1,052,678,681.27 | 964,410,910.21 | 713,894,369.05 |
| 资产总计 | 2,879,578,787.13 | 2,812,403,987.99 | 2,654,409,861.49 | 2,549,790,054.85 |
| 流动负债: | | | | |
| 流动负债合计 | 349,947,416.99 | 325,271,073.86 | 238,868,933.28 | 181,886,840.09 |
| 非流动负债: | | | | |
| 非流动负债合计 | 124,064,598.9 | 92,602,588.57 | 56,367,334.93 | 18,477,033.88 |
| 负债合计 | 474,012,015.89 | 417,873,662.43 | 295,236,268.21 | 200,363,873.97 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,400,509,588.75 | 2,388,885,790.33 | 2,352,847,561.37 | 2,349,426,180.88 |
| 股东权益合计 | 2,405,566,771.24 | 2,394,530,325.56 | 2,359,173,593.28 | 2,349,426,180.88 |
| 负债和股东权益合计 | 2,879,578,787.13 | 2,812,403,987.99 | 2,654,409,861.49 | 2,549,790,054.85 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 516,755,155.33 | 289,760,488.97 | 608,922,857.56 | 393,575,655.9 |
| 经营活动现金流出小计 | 389,829,293.81 | 214,926,595.09 | 531,253,264.94 | 345,852,527.31 |
| 经营活动产生的现金流量净额 | 126,925,861.52 | 74,833,893.88 | 77,669,592.62 | 47,723,128.59 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,153,538,209.52 | 1,264,753,887.63 | 5,740,794,446.49 | 4,031,521,486.09 |
| 投资活动现金流出小计 | 2,405,347,646.74 | 1,484,967,997.58 | 5,644,039,281.93 | 3,677,138,245.25 |
| 投资活动产生的现金流量净额 | -251,809,437.22 | -220,214,109.95 | 96,755,164.56 | 354,383,240.84 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 68,953,100.6 | 36,708,067.2 | 119,068,152.4 | 79,601,100 |
| 筹资活动现金流出小计 | 29,810,257.57 | 326,478.42 | 241,379,291.89 | 226,330,157.66 |
| 筹资活动产生的现金流量净额 | 39,142,843.03 | 36,381,588.78 | -122,311,139.49 | -146,729,057.66 |
| 汇率变动对现金及现金等价物的影响 | -4,132,396.19 | -1,511,526.52 | -6,710,583.67 | -3,639,489.76 |
| 现金及现金等价物净增加额 | -89,873,128.86 | -110,510,153.81 | 45,403,034.02 | 251,737,822.01 |
| 期末现金及现金等价物余额 | 316,610,944.07 | 295,973,326.14 | 406,484,072.93 | 612,818,860.92 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -89,873,128.86 | - | 45,403,034.02 | - |